Humana Touts Home Care Deals, Sees COVID Earnings Boost

Humana Inc.’s second quarter earnings exceeded investor expectations due to a drop in utilization, although the insurer expects spending on health care services to rebound somewhat as patients continue to return to medical facilities.

In its second quarter earnings report, Humana reported adjusted earnings per share (EPS) of $12.56. According to Jefferies analyst David Windley and Oppenheimer analyst Michael Wiederhorn, Wall Street anticipated an EPS of slightly over $10. Analysts anticipate a positive outlook for the rest of the year, but they hedged positive projections by noting the COVID-19 crisis could damage insurer earnings in unforeseen ways.

0 Comments
© 2024 MMIT
Peter Johnson

Peter Johnson

Peter has worked as a journalist since 2011 and has covered health care since 2020. At AIS Health, Peter covers trends in finance, business and policy that affect the health insurance and pharma sectors. For Health Plan Weekly, he covers all aspects of the U.S. health insurance sector, including employer-sponsored insurance, Medicaid managed care, Medicare Advantage and the Affordable Care Act individual marketplaces. In Radar on Drug Benefits, Peter covers the operations of (and conflicts between) pharmacy benefit managers and pharmaceutical manufacturers, with a particular focus on pricing dynamics and market access. Before joining AIS Health, Peter covered transportation, public safety and local government for various outlets in Seattle, his hometown and current place of residence. He graduated with a B.A. from Colby College.

Related Posts

medicare-part-c
May 17

Medicare, Medicaid Segments May Be a ‘Mess,’ but Bounce-Back Expected

READ MORE
hospital-hallway
May 17

As Hospitals’ Commercial Prices Keep Rising, Experts Float Solutions

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
May 17

News Briefs: CMS Extends Medicaid Redetermination Deadline

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today